WELCOME
- Hospital
- Kesavadev Trust
- Type 1
- Dreams
- Gems
- JPEF
- Clinical Research
- Publications
- Courses
- Knowledge Library
- WDD
- DTMS
Diabscreen Kerala is a major diabetes awareness project of P.Kesavadev Trust. The Diabscreen Kerala team, headed by Dr. Jothydev Kesavadev, conducts diabetes awareness, prevention, and treatment programs at various geographical locations in collaboration with regional organizations.
An initiative by P.Kesavadev Trust.
Venue: Golden Palms Spa, Resort N.Karnataka regional diabetes update by Novo Nordisk Speakers: Dr.A.K Das(JIPMER, Pondicherry) Dr.Harinarayana(Bangalore), Dr.Jothydev Kesavadev(Trivandrum) Dr.Dinakaran(Nephrologist, Madurai), Dr.Prasanna Kumar(novo), Dr.Vinay Prusty(Novo), Dr.Praful etc., Selected question and Answer Question from one doctor: You are known as the number one user of Insulin Pumps nation wide. In the absence of set guidelines, what are your criteria to deploy a pump in a type 2 diabetes patient? Answer by Dr.Jothydev Three years back when I started with pumps I used to deploy pumps in T2DM patients if they were affordable and requiring insulin.Now we have ourselves as I have shown in my slides published our experiences on using pumps in T2DM in India.Affordability is never the most important criteria since learning skills, home glucose monitoring, responsible care taker etc., are all mandatory. Pumps are not like insulins or medications, but only advanced delivery devices which should be used by skilled personnel with fully trained team working along with them. Question from one doctor: Are you using oral drugs along with pump therapy in T2DM? Ans by Jothydev Yes. In our abstract available at ADA web site we have clearly stated that. The requirement of insulin comes down with sensitisers and SU.More over we have to address the pathophysiology of T2DM, which is primarily insulin resistance and later on insulin secretory defect.